Clinical Trials on NAFLD - Nonalcoholic Fatty Liver Disease in France
Total 1120 results
-
Assistance Publique - Hôpitaux de ParisCompletedNonalcoholic Fatty Liver Disease (NAFLD)France
-
Merck Sharp & Dohme LLCRecruitingNon-alcoholic Fatty Liver Disease | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Fatty Liver, NonalcoholicCanada, United States, Puerto Rico, Japan, Korea, Republic of, Taiwan, Spain, Israel, Chile, France, Italy, Hungary, Switzerland, Belgium, China, Singapore, Czechia, Portugal, Austria, United Kingdom, Thailand, Hong Kong, Turkey, Colo... and more
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Nonalcoholic Fatty Liver Disease (NAFLD)United States, New Zealand
-
Hepion Pharmaceuticals, Inc.CompletedFibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NAFLD - Nonalcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Akero Therapeutics, IncRecruitingNASH/MASH | NAFLD/MASLDUnited States, Canada, Puerto Rico, Australia, India, Israel, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD)United States, Japan
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNAFLD | Nonalcoholic Steatohepatitis (NASH) | Fibrosis, LiverUnited States, France, Mexico
-
University of OxfordAssistance Publique - Hôpitaux de Paris; University of Nottingham; Novartis; Pf... and other collaboratorsActive, not recruitingNAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | NASH | Steatosis of LiverUnited Kingdom, Finland, Sweden, Spain, Greece, United States, Switzerland, Italy, France, Germany
-
Bristol-Myers SquibbCompletedNonalcoholic Steatohepatitis | Liver Fibrosis | Nonalcoholic Fatty Liver Disease (NAFLD) | Hepatic CirrhosisUnited States, Japan
-
HighTide Biopharma Pty LtdCompletedDigestive System Diseases | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM) | Fatty Liver, NonalcoholicUnited States
-
Rennes University HospitalCompletedFatty Liver | Non-alcoholic Fatty Liver DiseaseFrance
-
University Hospital, Strasbourg, FranceUnknownNonalcoholic Fatty Liver DiseaseFrance
-
Mativa-Tech SARecruitingNASH - Nonalcoholic SteatohepatitisFrance
-
Centre Hospitalier Universitaire de NiceRecruitingNon-Alcoholic Fatty Liver Disease (NAFLDFrance
-
University Hospital, GrenobleInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement...RecruitingHBV | NASH - Nonalcoholic SteatohepatitisFrance
-
Promethera TherapeuticsCompletedNASH - Nonalcoholic SteatohepatitisSpain, Belgium, Bulgaria, France
-
Merck Sharp & Dohme LLCCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Corcept TherapeuticsTerminatedNonalcoholic Steatohepatitis (NASH)United States
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Terns, Inc.Completed
-
University Hospital, AngersRecruiting
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Aligos TherapeuticsCompletedNASH - Nonalcoholic SteatohepatitisFrance
-
CymaBay Therapeutics, Inc.TerminatedNASH - Nonalcoholic SteatohepatitisUnited States
-
University Hospital, LilleMinistry of Health, FranceRecruitingObesity | Cirrhosis | Surgery | NASH - Nonalcoholic SteatohepatitisFrance
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
Meridian Bioscience, Inc.Conatus PharmaceuticalsCompletedCirrhosis | Portal Hypertension | NASH - Nonalcoholic SteatohepatitisFrance
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
NGM Biopharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Israel, Taiwan, Canada, Australia, Poland
-
Viking Therapeutics, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Mexico, Puerto Rico
-
Axcella Health, IncCompleted
-
GlaxoSmithKlineRecruitingNonalcoholic Fatty Liver DiseaseUnited States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
-
89bio, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.Active, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Spain, Australia, United Kingdom, Canada, Israel, Belgium, Italy, France, Puerto Rico, Switzerland, Germany, Austria, Poland, Mexico, Hungary
-
Bristol-Myers SquibbTerminatedNonalcoholic Fatty Liver DiseaseUnited States
-
Zydus Therapeutics Inc.CompletedNonalcoholic Steatohepatitis | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Mexico, Puerto Rico
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH) | Metabolic Dysfunction-associated Steatohepatitis (MASH)United States, Puerto Rico
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
University Hospital, LilleRégion Nord-Pas de Calais, France; RHU PreciNASH Task 1.4RecruitingObesity | NASH - Nonalcoholic SteatohepatitisFrance
-
Tokyo Medical UniversityRecruitingNonalcoholic Steatohepatitis | Elastography | UltrasoundUnited States, Korea, Republic of, Germany, Italy, China, France, Japan, United Kingdom
-
Bristol-Myers SquibbTerminatedNonalcoholic Steatohepatitis (NASH)United States, Germany, Taiwan, United Kingdom, Spain, Argentina, Brazil, France, Israel, Italy, Japan, Korea, Republic of, Belgium, Canada, Puerto Rico, Switzerland
-
Inventiva PharmaRecruitingNASH - Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Austria, Belgium, France, Germany, Israel, Portugal, Spain, United Kingdom, Canada, Italy, China, Brazil, Netherlands, Hungary, Bulgaria, Chile, Czechia, Mexico, Poland, Puerto Rico, South Africa, Uk...
-
Eli Lilly and CompanyCompletedNonalcoholic SteatohepatitisUnited States, Spain, Japan, United Kingdom, Belgium, France, Italy, Israel, Mexico, Poland
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Newcastle UniversityAssistance Publique - Hôpitaux de Paris; Medical University of Vienna; University... and other collaboratorsRecruitingCardiovascular Diseases | Hypertension | Obesity | Hepatocellular Carcinoma | Type 2 Diabetes | NAFLD | Fibrosis, Liver | NASH - Nonalcoholic Steatohepatitis | Dyslipidaemia | NASH | Steatosis of Liver | Other Associated ComorbiditiesNetherlands, Germany, United Kingdom, Finland, Belgium, Greece, Italy, Sweden, Portugal, Spain, France, Switzerland
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
GenfitTerminatedNonalcoholic Steatohepatitis (NASH) With FibrosisUnited States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more